{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:41Z","timestamp":1792631501598,"version":"4.5.0"},"reference-count":68,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sexual and gender minority (SGM) adolescents in the United States are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a highly effective biomedical HIV prevention method, but its awareness and uptake among SGM adolescents are low. There are no adolescent-centered PrEP social marketing campaigns in the United States that have the potential to increase awareness and interest in PrEP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To address this gap, this qualitative study aims to examine SGM adolescents\u2019 needs and preferences regarding adolescent-centered PrEP social marketing campaigns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SGM adolescents from Chicago and its surrounding areas participated in web-based asynchronous focus groups from February to May 2021. Questions elicited their preferences for content, design, and delivery of SGM adolescent\u2013centered PrEP campaigns. We used rapid qualitative data analysis and organized the findings around key components of social marketing, known as the 4 Ps: product, price, place, and promotion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants (N=56) were aged 14 to 19 years (mean 18.16, SD 1.22 y), and 64% (36\/56) of them identified as a racial or ethnic minority. Among the 56 participants, 70% (n=39) were aware of PrEP; however, 95% (n=53) did not know that PrEP could be prescribed to those aged under 18 years. Adolescents expressed a need for PrEP campaign messaging that provides simple, accurate, and easily accessible information (eg, what is PrEP, for whom PrEP is indicated, and where and how to access PrEP). For product and price, SGM adolescents wanted a campaign to address barriers to, costs of, and how to access PrEP and desired to know about other adolescents\u2019 PrEP experiences to improve campaign relatability. For place and promotion, participants preferred digital campaigns on social media to reduce the possibility of embarrassment and stigma and increase the accessibility of health content.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings lay the groundwork for designing adolescent-centered educational PrEP campaigns that prioritize both user preferences in PrEP marketing design and strategies to overcome common barriers to PrEP awareness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/60398","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:56:35Z","timestamp":1732611395000},"page":"e60398","source":"Crossref","is-referenced-by-count":8,"title":["Sexual and Gender Minority Adolescents\u2019 Preferences for HIV Pre-Exposure Prophylaxis Social Marketing Campaigns: Qualitative Preimplementation Study"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-6097","authenticated-orcid":false,"given":"Kathryn","family":"Macapagal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-6863","authenticated-orcid":false,"given":"Juan Pablo","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-1279","authenticated-orcid":false,"given":"Junye","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-5463","authenticated-orcid":false,"given":"Jacob D","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2729-151X","authenticated-orcid":false,"given":"Christopher","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5733-5246","authenticated-orcid":false,"given":"Silvia","family":"Valadez-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1536-3392","authenticated-orcid":false,"given":"Peter","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8122-1221","authenticated-orcid":false,"given":"Nathan","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4445-232X","authenticated-orcid":false,"given":"Jim","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref1","unstructured":"Understanding the current HIV epidemicAIDSVu2024-01-14https:\/\/aidsvu.org\/local-data\/united-states\/"},{"key":"ref2","unstructured":"HIV Surveillance Report, 2020; vol. 33Centers for Disease Control and Prevention202252024-12-25https:\/\/stacks.cdc.gov\/view\/cdc\/121127\/cdc_121127_DS1.pdf"},{"key":"ref3","unstructured":"HIV Surveillance Update ReportsIllinois Department of Public Health2025-1-10https:\/\/dph.illinois.gov\/topics-services\/diseases-and-conditions\/hiv-aids\/hiv-surveillance\/update-reports.html"},{"key":"ref4","unstructured":"Preventing HIV with PrEPCenters for Disease Control and Prevention2024-12-23https:\/\/www.cdc.gov\/hiv\/prevention\/prep.html"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001145"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"ref7","unstructured":"U.S. Food and Drug Administration approves expanded indication for Truvada\u00ae (emtricitabine and tenofovir disoproxil fumarate) for reducing the risk of acquiring HIV-1 in adolescentsGilead Sciences, Inc20182024-12-23https:\/\/www.gilead.com\/news\/news-details\/2018\/us-food-and-drug-administration-approves-expanded-indication-for-truvada-emtricitabine-and- tenofovir-disoproxil-fumarate-for-reducing-the-risk-of-acquiring-hiv-1-in-adolescents"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002613"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2020.05.032"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062599"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13178-020-00441-1"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-020-01904-7"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02827-z"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03313-w"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/1570162x12666140129100411"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001164"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.6536"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2125-2"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1480-0"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001837"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-016-0784-5"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-023-10244-4"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2017.11.047"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s13178-023-00826-y"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-019-1429-2"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2022.01.024"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.26.021304.144610"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hpja.13"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5993\/AJHB.24.1.2"},{"key":"ref30","unstructured":"Minor consent and confidentiality laws for HIV treatment and PrEP: AlabamaNational Alliance of State and Territorial AIDS Directors20222024-12-23https:\/\/nastad.org\/sites\/default\/files\/2022-02\/PDF_Minor_Consent_and_Confidentiality_Laws.pdf"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7551.1207-a"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/13691058.2020.1715482"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2196\/12822"},{"key":"ref34","unstructured":"#PrEP4LoveAIDSeS2024-12-27https:\/\/www.aides.org\/campagne\/prep4love"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000100"},{"key":"ref36","unstructured":"National youth HIV\/AIDS awareness dayCenters for Disease Control and Prevention2022-10-14https:\/\/www.cdc.gov\/healthyyouth\/youth_hiv\/resources.htm#:~:text=National%20Youth%20HIV%20%26%20AIDS%20Awareness %20Day%20(NYHAAD)%20is%20observed,health%20and%20safety%20of%20youth"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5993\/AJHB.24.1.6"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/hsw\/28.3.214"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2017.1407275"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/0093650219861256"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-052220-112457"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/1524500418761624"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-2-10"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/1468794105056916"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/1049732314523840"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/1049732316631510"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-011-0003-2"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2371-3"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112516"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/1609406917712131"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019993"},{"key":"ref52","unstructured":"Marketing campaign case studies: Trojan man campaignMarketing Campaign Case Studies20085132023-07-01https:\/\/marketing-case-studies.blogspot.com\/2008\/05\/trojan-man-campaign.html"},{"key":"ref53","unstructured":"MagnusonDHawkinsTMeraRAdolescent use of Truvada (FTC\/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States: (2012-2017)Proceedings of the 22nd International AIDS Conference2018AIDS 2018July 23-27, 2018Amsterdam, The Netherlands"},{"key":"ref54","first-page":"733-44","author":"Mustanski, B","year":"2023","journal-title":"AIDS and Behavior"},{"key":"ref55","unstructured":"Let's talk about it: preventing HIV with PrEPUS Preventive Services Task Force2024-12-23https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/sites\/default\/files\/inline-files\/hiv-prep-prevention-discussion-guide.pdf"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.19040"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2024.36.1.1"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0760-9"},{"key":"ref59","unstructured":"VogelsEAGelles-WatnickRMassaratNTeens, social media and technology 2022Pew Research Center20228102023-06-14https:\/\/www.pewresearch.org\/internet\/2022\/08\/10\/teens-social-media-and-technology-2022\/"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15061078"},{"key":"ref61","unstructured":"Mapping attacks on LGBTQ rights in U.S. state legislatures in 2024American Civil Liberties Union2024-03-01https:\/\/www.aclu.org\/legislative-attacks-on-lgbtq-rights-2024?state=NV"},{"key":"ref62","unstructured":"State legislation tracker: major developments in sexual and reproductive healthGuttmacher Institute2024-03-01https:\/\/www.guttmacher.org\/state-legislation-tracker"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10964-016-0415-4"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acdb.2015.11.006"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1177\/15248399211003544"},{"key":"ref66","unstructured":"PrEP4Teens homepagePrEP4Teens2024-04-04https:\/\/prep4teens.com\/about"},{"key":"ref67","unstructured":"Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2021 updateCenters for Disease Control and Prevention20212022-12-01https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf"},{"key":"ref68","unstructured":"Youth risk behavior surveillance system (YRBSS)Centers for Disease Control and Prevention2024-06-28https:\/\/www.cdc.gov\/yrbs\/about\/index.html"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e60398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:54:31Z","timestamp":1785851671000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e60398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":68,"URL":"https:\/\/doi.org\/10.2196\/60398","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.60398","asserted-by":"object"}]},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}